Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
What are the recent trends in market size and growth for the vancomycin market?
The vancomycin market size has grown rapidly in recent years. It will grow from $0.82 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, increasing global travel and trade, growing use in hospital settings, and increased healthcare spending.
The vancomycin market size is expected to see rapid growth in the next few years. It will grow to $1.4 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to the increasing emergence of novel pathogens, increasing demand for rapid and on-site testing solutions, growing emphasis on early detection systems, rising demand for vancomycin, and increased R&D activities. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies and integration of AI and machine learning algorithms into diagnostic platforms.
Get Your Free Sample of The Global Vancomycin Market Report:
Vancomycin Market Report 2025
How have varous drivers impacted the growth of the vancomycin market?
The rising prevalence of infectious diseases is expected to propel the growth of the vancomycin market going forward. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, encompassing conditions such as influenza, tuberculosis, malaria, HIV/AIDS, and COVID-19. The increasing prevalence of infectious diseases can be attributed to factors such as antimicrobial resistance, climate change, and population growth. Vancomycin is essential for treating severe gram-positive bacterial infections, especially resistant strains, guided by clinical guidelines and antimicrobial stewardship for optimal patient outcomes. For instance, in July 2023, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), a Switzerland-based United Nations program dedicated to addressing the global HIV/AIDS epidemic, the number of people with HIV (human immunodeficiency virus) currently exceeded 39 million globally in 2023, up 3.17% from 37.7 million in 2020. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based government agency, tuberculosis (TB) cases in the US increased by 5.9% from 7,874 cases in 2021 to 8,331 cases in 2022. Therefore, the rising prevalence of infectious diseases is driving the growth of the vancomycin market.
What are the primary segments of the vancomycin market?
The vancomycin market covered in this report is segmented –
1) By Type: Injectable Solution, Powder For Injection
2) By Route Of Administration: Intravenous, Oral
3) By Application: Sepsis, Lung Infection, Skin Soft Tissue Infection, Colitis And Intestinal Inflammation, To Prevent Infection
Subsegments:
1) By Injectable Solution: Pre-Mixed Injectable Solution, Ready-To-Use Injectable Solution, Concentrated Injectable Solution
2) By Powder For Injection: Vancomycin Powder For Intravenous Use, Vancomycin Powder For Reconstitution
Order your report now for swift delivery
Vancomycin Market Report 2025
Which firms are leading the vancomycin market?
Major companies operating in the vancomycin market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics Pvt. Ltd., DiaSorin SpA, Myriad Genetics Inc., Seegene Inc., ANI Pharmaceuticals Inc., Alvogen Inc., Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.
How will industry trends affect the trajectory of the vancomycin market?
Major companies operating in the vancomycin market are focused on developing innovative products, such as anti-infective and anti-hypotensive medications, to sustain their position in the market. Anti-infective medications are drugs used to treat infections caused by bacteria, viruses, fungi, parasites, or other microorganisms. Anti-hypotensive medications are drugs used to raise blood pressure in individuals experiencing low blood pressure (hypotension). For instance, in April 2024, Baxter International Inc., a US-based healthcare company, announced the launch of five injectable products in the US as part of its ongoing pharmaceutical portfolio growth. The new injectable products are designed to address specific medical needs, including advancements in anesthesia, pain management, and specialized therapies, reflecting the company’s commitment to providing healthcare professionals with practical tools to improve patient outcomes.
Which geographic trends are shaping the vancomycin market, and which region has the highest market share?
North America was the largest region in the vancomycin market in 2024. The regions covered in the vancomycin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Vancomycin Market Report 2025 Offer?
The vancomycin market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Vancomycin is a potent antibiotic used to treat infections caused by bacteria. It belongs to the class of antibiotics known as glycopeptides and is particularly effective against Gram-positive bacteria, including strains resistant to other antibiotics. Vancomycin works by inhibiting the synthesis of the bacterial cell wall, thereby preventing the bacteria from growing and multiplying.
Purchase the exclusive report now to unlock valuable market insights:
Vancomycin Market Report 2025
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Twitter: The Business Research Company (@tbrc_info) on X
Facebook: The Business Research Company | London
YouTube: The Business Research Company
Blog: Fructooligosaccharides Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities – Latest Global Market Insights
Healthcare Blog: Latest Healthcare Research Reports – By The Business Research Company
Global Market Model: Global Market Intelligence Database
